Q2 2023 Holdings
Filed 2023-08-11 | 43 holdings | $156.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $48.9M | 225,688 | 31.3% |
| Illumina Inc(ILMN) | COM | 452327109 | $22.3M | 119,196 | 14.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $13.0M | 368,665 | 8.3% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $9.1M | 47,096 | 5.8% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $8.0M | 651,100 | 5.1% |
| Exscientia PLC | ADS | 30223G102 | $5.1M | 859,892 | 3.3% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.4M | 111,984 | 2.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.4M | 114,380 | 2.8% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.4M | 113,950 | 2.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $4.3M | 184,739 | 2.7% |
| Merus N V | COM | N5749R100 | $4.0M | 151,000 | 2.5% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $3.9M | 1,696,558 | 2.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.1M | 12,022 | 1.4% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $2.0M | 493,584 | 1.3% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.0M | 32,022 | 1.3% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $1.9M | 613,223 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.8M | 204,720 | 1.2% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.8M | 136,655 | 1.2% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.5M | 1,166,952 | 1.0% |
| Geron Corp(GERN) | COM | 374163103 | $1.2M | 388,000 | 0.8% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.2M | 64,200 | 0.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $878.0K | 40,000 | 0.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $822.1K | 47,936 | 0.5% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $743.1K | 49,082 | 0.5% |
| Eargo Inc | COM NEW | 270087208 | $729.2K | 147,904 | 0.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $718.1K | 29,984 | 0.5% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $704.8K | 370,950 | 0.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $660.8K | 40,070 | 0.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $557.3K | 1,430 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $530.9K | 41,123 | 0.3% |
| Gitlab Inc(GTLB) | CLASS A COM | 37637K108 | $353.2K | 6,910 | 0.2% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $336.5K | 3,300 | 0.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $315.0K | 41,950 | 0.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $313.3K | 3,615 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $273.0K | 1,182 | 0.2% |
| Affimed N V | COM | N01045108 | $222.8K | 372,472 | 0.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $206.6K | 4,425 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $167.7K | 62,106 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $135.4K | 19,622 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $125.6K | 17,847 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $80.9K | 12,521 | 0.1% |
| Cerus Corp(CERS) | COM | 157085101 | $34.9K | 14,172 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $34.7K | 11,769 | 0.0% |